# ARTISS a Single-centre Randomised Control Study

> **NCT04931615** · PHASE4 · COMPLETED · sponsor: **Mid and South Essex NHS Foundation Trust** · enrollment: 135 (actual)

## Conditions studied

- Breast Neoplasms
- Mammaplasty

## Interventions

- **DRUG:** ARTISS 4mL Fibrin Sealant Topical Solution (Frozen)
- **OTHER:** no ARTISS

## Key facts

- **NCT ID:** NCT04931615
- **Lead sponsor:** Mid and South Essex NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-01
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 135 (ACTUAL)
- **Last updated:** 2024-03-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04931615

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04931615, "ARTISS a Single-centre Randomised Control Study". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04931615. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*